Physical Activity, Fatty Liver, and Glucose Metabolism Over the Life Course: The Lifelines Cohort
- PMID: 30865013
- DOI: 10.14309/ajg.0000000000000168
Physical Activity, Fatty Liver, and Glucose Metabolism Over the Life Course: The Lifelines Cohort
Abstract
Objectives: We examined the dose-dependent association of habitual moderate-to-vigorous physical activity (MVPA) with the biochemical markers for nonalcoholic fatty liver disease (NAFLD) and whether this association changes with age and degree of impaired glucose metabolism. We also investigated whether the associations depend on the domain of MVPA.
Methods: In this study, using data from the population-based Lifelines cohort (N = 42,661), MVPA was self-reported on the short questionnaire to assess health-enhancing physical activity. NAFLD was defined as a fatty liver index value of >60, based on body mass index, waist circumference, plasma triglycerides, and gamma-glutamyltransferase. Glucose metabolism was defined as normal (NGM), impaired (IGM), and type 2 diabetes mellitus (T2DM). Exclusion criteria were previously diagnosed hepatitis or cirrhosis and excessive alcohol use. All analyses were adjusted for age, sex, and education.
Results: Higher MVPA was dose dependently associated with a lower risk of having NAFLD: compared with "No MVPA," the odds ratios (ORs) (95% confidence intervals) for MVPA quintiles were 0.78 (0.71-0.86), 0.64 (0.58-0.70), 0.53 (0.48-0.59), 0.51 (0.46-0.56), and 0.45 (0.41-0.50) for the highest level of MVPA. The association between MVPA and NAFLD was stronger for more impaired glucose status (ORNGM = 0.49 (0.42-0.57), ORIGM = 0.46 (0.40-0.54), ORT2DM = 0.42 (0.27-0.66)) and for older age (OR20-40 years = 0.51 (0.42-0.62), OR60-80 years = 0.37 (0.29-0.48)) with the highest level of MVPA, relative to No MVPA. No favorable association was observed for occupational MVPA. With regard to MVPA and fibrosis, associations with fibrosis markers showed contradictory results.
Conclusions: Higher MVPA levels are dose dependently associated with a lower NAFLD risk. This association is stronger in people with diabetes and older adults.
Similar articles
-
Higher free triiodothyronine is associated with non-alcoholic fatty liver disease in euthyroid subjects: the Lifelines Cohort Study.Metabolism. 2017 Feb;67:62-71. doi: 10.1016/j.metabol.2016.11.002. Epub 2016 Nov 6. Metabolism. 2017. PMID: 28081779
-
Gender impacts on the correlations between nonalcoholic fatty liver disease and hypertension in a Chinese population aged 45-60 y.Clin Exp Hypertens. 2016;38(7):639-643. doi: 10.1080/10641963.2016.1182181. Epub 2016 Sep 28. Clin Exp Hypertens. 2016. PMID: 27680771
-
Fatty liver index vs waist circumference for predicting non-alcoholic fatty liver disease.World J Gastroenterol. 2016 Mar 14;22(10):3023-30. doi: 10.3748/wjg.v22.i10.3023. World J Gastroenterol. 2016. PMID: 26973398 Free PMC article.
-
The Association Between Nonalcoholic Fatty Liver Disease and Metabolic Abnormalities in The United States Population.J Clin Gastroenterol. 2017 Feb;51(2):160-166. doi: 10.1097/MCG.0000000000000666. J Clin Gastroenterol. 2017. PMID: 27580477 Free PMC article.
-
The role of incretin hormones and glucagon in patients with liver disease.Dan Med J. 2017 May;64(5):B5363. Dan Med J. 2017. PMID: 28552096 Review.
Cited by
-
MASLD treatment-a shift in the paradigm is imminent.Front Med (Lausanne). 2023 Dec 11;10:1316284. doi: 10.3389/fmed.2023.1316284. eCollection 2023. Front Med (Lausanne). 2023. PMID: 38146424 Free PMC article. Review.
-
Associations of physical activity domains and muscle strength exercise with non-alcoholic fatty liver disease: a nation-wide cohort study.Sci Rep. 2023 Mar 23;13(1):4724. doi: 10.1038/s41598-023-31686-6. Sci Rep. 2023. PMID: 36959316 Free PMC article.
-
Association Between Different Types of Physical Activity and Hepatic Steatosis and Liver Fibrosis: A Cross-Sectional Study Based on NHANES.J Clin Gastroenterol. 2025 Feb 1;59(2):168-176. doi: 10.1097/MCG.0000000000001985. J Clin Gastroenterol. 2025. PMID: 38457411 Free PMC article.
-
Dietary Interventions and Physical Activity as Crucial Factors in the Prevention and Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease.Biomedicines. 2025 Jan 16;13(1):217. doi: 10.3390/biomedicines13010217. Biomedicines. 2025. PMID: 39857800 Free PMC article. Review.
-
Pharmacological Treatment of MASLD: Contemporary Treatment and Future Perspectives.Int J Mol Sci. 2025 Jul 7;26(13):6518. doi: 10.3390/ijms26136518. Int J Mol Sci. 2025. PMID: 40650294 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical